THE GOLD STANDARD IN THIRD-PARTY CERTIFICATION AND TESTING : +1-800-920-6605, info@bscg.org
Sep 30, 2026
A single pathogen finding or out-of-specification microbial count can halt production, delay a launch, trigger product holds, and create recall considerations that affect an entire brand.
This is not theoretical. In early 2026, a Salmonella outbreak associated with moringa leaf powder led to 45 reported cases across 21 states and recalls involving several supplement brands.
Microbiological testing is essential to preventing outcomes like these. But effective testing is not simply a matter of applying one universal microbial limit to every product. It requires risk-based specifications, appropriate methods, qualified suppliers, sound manufacturing controls, and disciplined decisions when a result falls outside specification.
A comprehensive microbiological testing program generally evaluates:
BSCG conducts testing for core microbiological agents including plate count, yeast and mold, coliform, E. coli, Staphylococcus aureus, and Salmonella.
Each result tells part of the quality story. Elevated total aerobic counts may indicate issues with raw-material quality, sanitation, storage, or process control. Yeast and mold are especially important for botanicals and powders, which can be exposed to fungal contamination during cultivation, drying, handling, and transport. Pathogens demand close attention because their presence can directly create a consumer-safety concern.
The right limits depend on the product. A botanical powder, probiotic, gummy, capsule, oil, or liquid supplement does not carry the same microbial risk profile. Product form, ingredient origin, moisture level, processing history, packaging, and intended consumer all matter.
Microbial contamination frequently originates upstream.
Raw agricultural materials can naturally carry higher microbial loads. Botanicals, animal-derived ingredients, and moisturesensitive materials deserve particular scrutiny. A peer-reviewed review of plant-containing supplements found a range of potential microbial contaminants, reinforcing the value of supplier qualification and incoming-material controls.
A supplier certificate of analysis is useful documentation, but it is not automatically a substitute for independent verification. Brands should evaluate supplier testing methods, review certificates of analysis, audit supplier specifications where appropriate, and include periodic verification in their quality systems.
Low-moisture products are not exempt. Tablets and capsules may limit microbial growth through reduced water activity, but they can still contain organisms introduced through raw materials, blending, handling, or manufacturing. The issue is not only whether microbes can grow in the final product; it is also whether the product meets its established specifications.
Products with higher moisture, such as liquids and gummies, require additional attention. The FDA notes that foods with water activity above 0.95 can support bacterial, yeast, and mold growth. In these products, preservation systems, packaging integrity, and shelf-life monitoring become especially important.
Recognized testing methods provide the framework, but method suitability is what makes results meaningful.
USP General Chapters 2021 and 2022 address microbial enumeration and testing for specified organisms. Other validated approaches, including AOAC, ISO, and rapid microbiology methods, may also be appropriate when their suitability for the specific product matrix has been demonstrated.
This matters for complex formulations. Botanicals, minerals, oils, gummies, probiotics, and blended powders can interfere with testing or require tailored preparation methods. Probiotic products are a good example. Testing must confirm the label claim for intended organisms while also screening for unwanted contaminants. Methods may need adjustment so the intended probiotic strains do not mask the organisms the laboratory is trying to detect.
Testing is only reliable when it is appropriate for the product being tested.
When a microbial result falls outside specification, the correct response is not to keep retesting until a passing result appears.
The affected batch should be placed on hold. The initial laboratory result should be reviewed and verified according to established procedures. Sample handling, traceability, method suitability, and laboratory controls should all be assessed. Related batches may also need to be held while the investigation proceeds.
Then comes the larger question: where did the problem originate?
A thorough root-cause investigation should examine raw-material records, supplier documentation, manufacturing logs, sanitation practices, environmental conditions, storage, packaging, and potential cross-contamination risks. The outcome should lead to documented corrective and preventive actions, which may include supplier corrective action requests, process changes, sanitation improvements, revised specifications, or additional verification testing.
Finished-product testing is vital, but it does not prevent contamination. It confirms whether the product meets specification at release. Prevention requires effective supplier oversight, GMP controls, sanitation, environmental management, and disciplined quality documentation throughout the process.
Independent testing can strengthen a supplement brand’s quality program by verifying whether established specifications are being met. It can also support product-release decisions, retailer requirements, regulatory documentation, and consumer confidence.
BSCG works exclusively with ISO/IEC 17025-accredited laboratories and includes microbiological verification in its Certified Quality program. BSCG also provides analytical testing that can help brands meet Amazon and other retailer requirements.
Third-party testing does not eliminate all risk in every unit of a product. Sampling plans have limits. But independent verification, combined with a strong internal GMP system, creates a more defensible and reliable approach to product quality.
The takeaway is straightforward: dietary supplements are not generally required to be sterile, but they must meet scientifically justified quality specifications and should not contain microorganisms or pathogen levels that present a safety risk.
For brands, microbial testing should not be treated as a box to check at the end of production. It is one part of a broader, riskbased quality system designed to identify problems early, support sound release decisions, and protect consumers before product reaches the market.
YouTube Channel
Oliver Catlin Interview
BSCG BLOG
Nutraceutical Testing Checklist: What to Request Before Launching a Supplement
The Catlin Perspective blog widget
THE HISTORY OF BSCG